Skip to content

Curcumin review finds a modest systolic blood pressure reduction

Trials in adults with prediabetes or type 2 diabetes found lower systolic pressure with supplementation, while the overall diastolic result was not statistically significant.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Supplementation produced a modest average reduction in systolic blood pressure, the study's clearest overall result. The pooled diastolic estimate was uncertain and did not reach statistical significance. These findings apply to adults with prediabetes or diabetes in the included trials; they do not establish that supplementation prevents cardiovascular events or identify an optimal dose.

Keep in mind

This abstract-based summary lacks treatment durations and details of the control regimens. Diastolic findings varied substantially across studies, and subgroup results do not establish that a particular formulation or dose is superior.

THE NUMBERS, WITH CONTEXT

What researchers found

-2.69 mmHg (95% CI: -3.84 to -1.55)

Systolic blood pressure

Weighted mean difference versus control groups; treatment durations were not reported in the abstract.

Endocrinol Diabetes Metab, 2026 · Original source ↓

The overall results differed

The review assessed systolic and diastolic pressure separately. Although the average diastolic estimate favored supplementation, its confidence interval included no difference, leaving uncertainty about whether supplementation meaningfully changes that measure.

Subgroups need careful interpretation

The authors also examined subgroups based on initial blood pressure, diagnosis, weight, formulation, and dose. Significant findings within some subgroups do not demonstrate that those groups benefited more than others in a direct comparison.

CHECK THE ORIGINAL

The original publication

Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Bahari H, Sharifi M, Nejad Shahrokh Abadi Z et al.
Endocrinol Diabetes Metab · 2026

PubMed ID
41388744
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.